BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19129496)

  • 1. Rb/Cdk2/Cdk4 triple mutant mice elicit an alternative mechanism for regulation of the G1/S transition.
    Li W; Kotoshiba S; Berthet C; Hilton MB; Kaldis P
    Proc Natl Acad Sci U S A; 2009 Jan; 106(2):486-91. PubMed ID: 19129496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdc2-cyclin E complexes regulate the G1/S phase transition.
    Aleem E; Kiyokawa H; Kaldis P
    Nat Cell Biol; 2005 Aug; 7(8):831-6. PubMed ID: 16007079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined loss of Cdk2 and Cdk4 results in embryonic lethality and Rb hypophosphorylation.
    Berthet C; Klarmann KD; Hilton MB; Suh HC; Keller JR; Kiyokawa H; Kaldis P
    Dev Cell; 2006 May; 10(5):563-73. PubMed ID: 16678773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
    Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
    Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity.
    Tsutsui T; Hesabi B; Moons DS; Pandolfi PP; Hansel KS; Koff A; Kiyokawa H
    Mol Cell Biol; 1999 Oct; 19(10):7011-9. PubMed ID: 10490638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mathematical model of the regulation of the G1 phase of Rb+/+ and Rb-/- mouse embryonic fibroblasts and an osteosarcoma cell line.
    Obeyesekere MN; Knudsen ES; Wang JY; Zimmerman SO
    Cell Prolif; 1997; 30(3-4):171-94. PubMed ID: 9375029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells.
    Cheng L; Rossi F; Fang W; Mori T; Cobrinik D
    J Biol Chem; 2000 Sep; 275(39):30317-25. PubMed ID: 10906146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p21 is a critical CDK2 regulator essential for proliferation control in Rb-deficient cells.
    Brugarolas J; Bronson RT; Jacks T
    J Cell Biol; 1998 Apr; 141(2):503-14. PubMed ID: 9548727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
    Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
    Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
    J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice thrive without Cdk4 and Cdk2.
    Barrière C; Santamaría D; Cerqueira A; Galán J; Martín A; Ortega S; Malumbres M; Dubus P; Barbacid M
    Mol Oncol; 2007 Jun; 1(1):72-83. PubMed ID: 19383288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
    Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
    Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of cdk4 and cdk2 during rat liver regeneration is associated with intranuclear rearrangements of cyclin-cdk complexes.
    Jaumot M; Estanyol JM; Serratosa J; Agell N; Bachs O
    Hepatology; 1999 Feb; 29(2):385-95. PubMed ID: 9918914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cdk4/6-dependent phosphorylation gradient regulates the early to late G1 phase transition.
    Kaulich M; Link VM; Lapek JD; Lee YJ; Glass CK; Gonzalez DJ; Dowdy SF
    Sci Rep; 2021 Jul; 11(1):14736. PubMed ID: 34282211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic characterization of p27(kip1) and stathmin in controlling cell proliferation in vivo.
    Berton S; Pellizzari I; Fabris L; D'Andrea S; Segatto I; Canzonieri V; Marconi D; Schiappacassi M; Benevol S; Gattei V; Colombatti A; Belletti B; Baldassarre G
    Cell Cycle; 2014; 13(19):3100-11. PubMed ID: 25486569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.
    Baghdassarian N; Catallo R; Mahly MA; Ffrench P; Chizat F; Bryon PA; Ffrench M
    Exp Cell Res; 1998 May; 240(2):263-73. PubMed ID: 9596999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction.
    Ponzio G; Loubat A; Rochet N; Turchi L; Rezzonico R; Farahi Far D; Dulic V; Rossi B
    Oncogene; 1998 Sep; 17(9):1159-66. PubMed ID: 9764826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.